Verastem, Inc. (NASDAQ:VSTM)
Verastem, Inc. (NASDAQ:VSTM) represented a move of -2.22 percent or $0.58 per share and closed its previous day trading session at $5.72. 4.87 Million Shares were traded in the last trading session with an Average Volume of 3.18 Million Shares. The stock currently has a Market Capitalization of 422.54 Million.
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company’s defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
The stock traded between $ 2.77 and $10.35 over 1-Year time period showing its price to sales ratio of 42.25. Verastem, Inc. (NASDAQ:VSTM) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-19.54 and 200-Day Simple Moving Average of $-1.3. Its Price to Free Cash Flow is 0 and Price to Book of 2.76.
Analyst’s recommended the stock as 1.7 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Verastem, Inc. (NASDAQ:VSTM) reported its Actual EPS of $-0.3/share. The analysts offering Earnings Estimates for the company were believing that Verastem, Inc. could bring EPS of $-0.34/share. The difference between Actual EPS and Estimated EPS was 0.04 Percent. Thus showing an Earnings Surprise of 11.8 Percent.
Laredo Petroleum, Inc. (NYSE:LPI)
In the last trading session, Laredo Petroleum, Inc. (NYSE:LPI) added its value by 0.69% closing at the price of $5.85. The stock currently has market capitalization of 1.45 Billion, with average volume of 5.75 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Laredo Petroleum, Inc. (NYSE:LPI) is showing beta of 1.68. This particular value of beta suggests that Laredo Petroleum, Inc. (NYSE:LPI) has historically moved 168% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Laredo Petroleum, Inc. (NYSE:LPI) is at $2.26.
The stock currently has RSI of 43.75. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Laredo Petroleum Holdings, Inc. is engaged in the exploration, development and acquisition of oil and natural gas properties in the Permian and Mid-Continent regions of the United States. Laredo Petroleum Holdings, Inc. is headquartered in Tulsa, Oklahoma.
Laredo Petroleum, Inc. (NYSE:LPI) topped its 52-week high price of $11.68 on 01/24/18 and 52-Week Low Price of $ 4.82 on 10/30/18. The Stock currently has P/E (price to earnings ttm) of 2.59 and Weekly volatility of 7.29% and monthly volatility of 6.33% respectively.